637 related articles for article (PubMed ID: 22877147)
21. Hypoxia induced aggressiveness of prostate cancer cells is linked with deregulated expression of VEGF, IL-6 and miRNAs that are attenuated by CDF.
Bao B; Ahmad A; Kong D; Ali S; Azmi AS; Li Y; Banerjee S; Padhye S; Sarkar FH
PLoS One; 2012; 7(8):e43726. PubMed ID: 22952749
[TBL] [Abstract][Full Text] [Related]
22. Cancer stem cell niche: the place to be.
Borovski T; De Sousa E Melo F; Vermeulen L; Medema JP
Cancer Res; 2011 Feb; 71(3):634-9. PubMed ID: 21266356
[TBL] [Abstract][Full Text] [Related]
23. Breast cancer stem cells: an update.
Iqbal J; Chong PY; Tan PH
J Clin Pathol; 2013 Jun; 66(6):485-90. PubMed ID: 23322821
[TBL] [Abstract][Full Text] [Related]
24. Cancer stem cells and angiogenesis.
Zhao Y; Bao Q; Renner A; Camaj P; Eichhorn M; Ischenko I; Angele M; Kleespies A; Jauch KW; Bruns C
Int J Dev Biol; 2011; 55(4-5):477-82. PubMed ID: 21732274
[TBL] [Abstract][Full Text] [Related]
25. Snail1-driven plasticity of epithelial and mesenchymal cells sustains cancer malignancy.
Baulida J; García de Herreros A
Biochim Biophys Acta; 2015 Aug; 1856(1):55-61. PubMed ID: 26050961
[TBL] [Abstract][Full Text] [Related]
26. Epithelial-mesenchymal transition: a hallmark in metastasis formation linking circulating tumor cells and cancer stem cells.
Książkiewicz M; Markiewicz A; Zaczek AJ
Pathobiology; 2012; 79(4):195-208. PubMed ID: 22488297
[TBL] [Abstract][Full Text] [Related]
27. Cancer stem cells and mesenchymal stem cells in the hypoxic tumor niche: two different targets for one only drug.
Bonafè F; Guarnieri C; Muscari C
Med Hypotheses; 2015 Mar; 84(3):227-30. PubMed ID: 25620576
[TBL] [Abstract][Full Text] [Related]
28. Emerging role of microRNAs in cancer and cancer stem cells.
Hao J; Zhao S; Zhang Y; Zhao Z; Ye R; Wen J; Li J
J Cell Biochem; 2014 Apr; 115(4):605-10. PubMed ID: 24166873
[TBL] [Abstract][Full Text] [Related]
29. Cancer stem cells: problems for therapy?
Alison MR; Lim SM; Nicholson LJ
J Pathol; 2011 Jan; 223(2):147-61. PubMed ID: 21125672
[TBL] [Abstract][Full Text] [Related]
30. Cancer stem cells and tumor metastasis.
Sun S; Qiu XS
J Cancer Res Ther; 2013 Nov; 9 Suppl():S150-2. PubMed ID: 24516051
[TBL] [Abstract][Full Text] [Related]
31. Cancer stem cells and their potential implications for the treatment of solid tumors.
Grotenhuis BA; Wijnhoven BP; van Lanschot JJ
J Surg Oncol; 2012 Aug; 106(2):209-15. PubMed ID: 22371125
[TBL] [Abstract][Full Text] [Related]
32. The biological kinship of hypoxia with CSC and EMT and their relationship with deregulated expression of miRNAs and tumor aggressiveness.
Bao B; Azmi AS; Ali S; Ahmad A; Li Y; Banerjee S; Kong D; Sarkar FH
Biochim Biophys Acta; 2012 Dec; 1826(2):272-96. PubMed ID: 22579961
[TBL] [Abstract][Full Text] [Related]
33. Epithelial to mesenchymal transition and cancer stem cell phenotypes leading to liver metastasis are abrogated by the novel TGFβ1-targeting peptides P17 and P144.
Zubeldia IG; Bleau AM; Redrado M; Serrano D; Agliano A; Gil-Puig C; Vidal-Vanaclocha F; Lecanda J; Calvo A
Exp Cell Res; 2013 Feb; 319(3):12-22. PubMed ID: 23153552
[TBL] [Abstract][Full Text] [Related]
34. The therapeutic potential of targeting the epithelial-mesenchymal transition in cancer.
Ginnebaugh KR; Ahmad A; Sarkar FH
Expert Opin Ther Targets; 2014 Jul; 18(7):731-45. PubMed ID: 24758643
[TBL] [Abstract][Full Text] [Related]
35. The bad seed: Cancer stem cells in tumor development and resistance.
Koren E; Fuchs Y
Drug Resist Updat; 2016 Sep; 28():1-12. PubMed ID: 27620951
[TBL] [Abstract][Full Text] [Related]
36. Pancreatic cancer stem cells: new insight into a stubborn disease.
Zhan HX; Xu JW; Wu D; Zhang TP; Hu SY
Cancer Lett; 2015 Feb; 357(2):429-37. PubMed ID: 25499079
[TBL] [Abstract][Full Text] [Related]
37. Epithelial plasticity, cancer stem cells, and the tumor-supportive stroma in bladder carcinoma.
van der Horst G; Bos L; van der Pluijm G
Mol Cancer Res; 2012 Aug; 10(8):995-1009. PubMed ID: 22714124
[TBL] [Abstract][Full Text] [Related]
38. The Microenvironment of Lung Cancer and Therapeutic Implications.
Mittal V; El Rayes T; Narula N; McGraw TE; Altorki NK; Barcellos-Hoff MH
Adv Exp Med Biol; 2016; 890():75-110. PubMed ID: 26703800
[TBL] [Abstract][Full Text] [Related]
39. Cancer Stem Cells: Acquisition, Characteristics, Therapeutic Implications, Targeting Strategies and Future Prospects.
Yadav AK; Desai NS
Stem Cell Rev Rep; 2019 Jun; 15(3):331-355. PubMed ID: 30993589
[TBL] [Abstract][Full Text] [Related]
40. Targeting miRNAs involved in cancer stem cell and EMT regulation: An emerging concept in overcoming drug resistance.
Wang Z; Li Y; Ahmad A; Azmi AS; Kong D; Banerjee S; Sarkar FH
Drug Resist Updat; 2010; 13(4-5):109-18. PubMed ID: 20692200
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]